HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection

被引：118
|
作者：
Kemp, Troy J. [1 ]
Hildesheim, Allan [2 ]
Safaeian, Mahboobeh [2 ]
Dauner, Joseph G. [1 ]
Pan, Yuanji [1 ]
Porras, Carolina [3 ]
Schiller, John T. [4 ]
Lowy, Douglas R. [4 ]
Herrero, Rolando [3 ]
Pinto, Ligia A. [1 ]
机构：
[1] NCI Frederick, HPV Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA
[2] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[3] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica
[4] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
VACCINE | 2011年 / 29卷 / 11期
基金：
美国国家卫生研究院;
关键词：
Human papillomavirus; Antibody; Vaccine; PARTICLE VACCINE; YOUNG-WOMEN; INFECTION; EFFICACY; IMMUNIZATION; RESPONSES; TYPE-18; HPV-18;
D O I：
10.1016/j.vaccine.2011.01.001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Human papillomavirus (HPV) L1 VLP-based vaccines are protective against HPV vaccine-related types; however, the correlates of protection have not been defined. We observed that vaccination with Cervarix (TM) induced cross-neutralizing antibodies for HPV types for which evidence of vaccine efficacy has been demonstrated (HPV31/45) but not for other types (HPV52/58). In addition, HPV31/45 cross-neutralizing titers showed a significant increase with number of doses (HPV31, p < 0.001; HPV45, p < 0.001) and correlated with HPV16/18 neutralizing titers, respectively. These findings raise the possibility that cross-neutralizing antibodies are effectors of cross-protection observed for the HPV16/18 vaccine.(C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2011 / 2014
页数：4
相关论文
共 48 条
  • [21] Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
    Giannini, Sandra L.
    Hanon, Emmanuel
    Moris, Philippe
    Van Mechelen, Marcelle
    Morel, Sandra
    Dessy, Francis
    Fourneau, Marc A.
    Colau, Brigitte
    Suzich, Joann
    Losonksy, Genevieve
    Martin, Marie-Therese
    Dubin, Gary
    Wettendorff, Martine A.
    VACCINE, 2006, 24 (33-34) : 5937 - 5949
  • [22] Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection
    Handabile, Chimuka
    Sekiya, Toshiki
    Nomura, Naoki
    Ohno, Marumi
    Kawakita, Tomomi
    Shingai, Masashi
    Kida, Hiroshi
    VACCINES, 2022, 10 (05)
  • [23] Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females
    Yokomine, Masay
    Matsueda, Satoko
    Kawano, Kouichiro
    Sasada, Tetsuro
    Fukui, Akimasa
    Yamashita, Takuto
    Komatsu, Nobukazu
    Shichijo, Shigeki
    Tasaki, Kazuto
    Matsukuma, Ken
    Itoh, Kyogo
    Kamura, Toshiharu
    Ushijima, Kimio
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (04) : 1500 - 1505
  • [24] Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
    Mariz, Filipe Colaco
    Bender, Noemi
    Anantharaman, Devasena
    Basu, Partha
    Bhatla, Neerja
    Pillai, Madhavan Radhakrisna
    Prabhu, Priya R.
    Sankaranarayanan, Rengaswamy
    Eriksson, Tiina
    Pawlita, Michael
    Prager, Kristina
    Sehr, Peter
    Waterboer, Tim
    Mueller, Martin
    Lehtinen, Matti
    NPJ VACCINES, 2020, 5 (01)
  • [25] Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles
    Boxus, Mathieu
    Fochesato, Michel
    Miseur, Agnes
    Mertens, Emmanuel
    Dendouga, Najoua
    Brendle, Sarah
    Balogh, Karla K.
    Christensen, Neil D.
    Giannini, Sandra L.
    JOURNAL OF VIROLOGY, 2016, 90 (14) : 6314 - 6325
  • [26] Protein transduction domain can enhance the humoral immunity and cross-protection of HPV16L2 peptide vaccines
    Li, Lili
    Guo, Yantao
    Li, Zelin
    Zhou, Yubai
    Zeng, Yi
    BIOMEDICAL REPORTS, 2016, 4 (06) : 746 - 750
  • [27] An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults
    Widge, Alicia T.
    Hofstetter, Amelia R.
    V. Houser, Katherine
    Awan, Seemal F.
    Chen, Grace L.
    Florez, Maria C. Burgos
    Berkowitz, Nina M.
    Mendoza, Floreliz
    Hendel, Cynthia S.
    Holman, LaSonji A.
    Gordon, Ingelise J.
    Apte, Preeti
    Liang, C. Jason
    Gaudinski, Martin R.
    Coates, Emily E.
    Strom, Larisa
    Wycuff, Diane
    Vazquez, Sandra
    Stein, Judy A.
    Gall, Jason G.
    Adams, William C.
    Carlton, Kevin
    Gillespie, Rebecca A.
    Creanga, Adrian
    Crank, Michelle C.
    Andrews, Sarah F.
    Castro, Mike
    Serebryannyy, Leonid A.
    Narpala, Sandeep R.
    Hatcher, Christian
    Lin, Bob C.
    O'Connell, Sarah
    Freyn, Alec W.
    Rosado, Victoria C.
    Nachbagauer, Raffael
    Palese, Peter
    Kanekiyo, Masaru
    McDermott, Adrian B.
    Koup, Richard A.
    Dropulic, Lesia K.
    Graham, Barney S.
    Mascola, John R.
    Ledgerwood, Julie E.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (692)
  • [28] A novel fluorescence immunoassay for the quantitative detection of HPV16 L1 antibodies in human serum samples using ZnCdSe/ZnS quantum dot-labeled antibodies
    Wang, Aiping
    Xin, Cheng
    Chen, Zhuting
    Zhou, Jingming
    Chen, Yumei
    Liu, Yankai
    Liu, Hongliang
    Liang, Chao
    Zhu, Xifang
    Qi, Yanhua
    Zhang, Gaiping
    MICROBIOLOGY SPECTRUM, 2025,
  • [29] Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge
    Robinson, Sally R.
    Rahe, Michael C.
    Gray, Diem K.
    Martins, Kyra V.
    Murtaugh, Michael P.
    VIRUS RESEARCH, 2018, 248 : 13 - 23
  • [30] A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
    Tumban, Ebenezer
    Peabody, Julianne
    Peabody, David S.
    Chackerian, Bryce
    PLOS ONE, 2011, 6 (08):
12345